Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencing

Clinical and Translational Immunology

Volumn 5, Issue 7, 2016, Pages

  Vigdorovich, Vladimir ^a   Oliver, Brian G ^a   Carbonetti, Sara ^a   Dambrauskas, Nicholas ^a   Lange, Miles D ^a   Yacoob, Christina ^b   Leahy, Will ^c   Callahan, Jonathan ^c   Stamatatos, Leonidas ^b   Sather, D Noah ^a  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Mazama Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010849015     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.42     Document Type: Article

References (70)

1. Evans DT, Silvestri G. Nonhuman primate models in AIDS research. Curr Opin HIV AIDS 2013; 8: 255–261.
2. Mangus LM, Dorsey JL, Laast VA, Ringkamp M, Ebenezer GJ, Hauer P et al. Unraveling the pathogenesis of HIV peripheral neuropathy: insights from a simian immunodeficiency virus macaque model. ILAR J 2014; 54: 296–303.
3. Peña JC, Ho W-Z. Monkey models of tuberculosis: lessons learned. Infect Immun 2015; 83: 852–862.
4. Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM. Modeling Parkinson’s disease in monkeys for translational studies, a critical analysis. Exp Neurol 2014; 256: 133–143.
5. Pound LD, Kievit P, Grove KL. The nonhuman primate as a model for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2014; 21: 89–94.
6. Vallender EJ, Miller GM. Nonhuman primate models in the genomic era: a paradigm shift. ILAR J 2013; 54: 154–165.
7. Vierboom M, Breedveld E, ’t Hart BA. New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis. Expert Opin Drug Discov 2012; 7: 315–325.
8. Wang F. Nonhuman primate models for Epstein-Barr virus infection. Curr Opin Virol 2013; 3: 233–237.
9. Clark KB, Onlamoon N, Hsiao H-M, Perng GC, Villinger F. Can non-human primates serve as models for investigating dengue disease pathogenesis? Front Microbiol 2013; 4: 305.
10. Martins K, Cooper C, Warren T, Wells J, Bell T, Raymond J et al. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques. Viral Immunol 2015; 28: 32–41.
11. Shen S, Pyo C-W, Vu Q, Wang R, Geraghty DE. The essential detail: the genetics and genomics of the primate immune response. ILAR J 2013; 54: 181–195.
12. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, Else JG et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15: 861–865.
13. Weinfurter JT, May GE, Soma T, Hessell AJ, León EJ, Macnair CE et al. Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus. JVirol2011; 85: 530–541.
14. Schmitz JE, Korioth-Schmitz B. Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates. Curr Opin HIV AIDS 2013; 8: 273–279.
15. Zhou Y, Bao R, Haigwood NL, Persidsky Y, Ho WZ. SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans. Retrovirology 2013; 10: 89.
16. Chen Z, Zhao X, Huang Y, Gettie A, Ba L, Blanchard J et al. CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV). JAcquirImmuneDefic Syndr 2002; 30: 133–145.
17. Gautam R, Nishimura Y, Lee WR, Donau O, Buckler-White A, Shingai M et al. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immuno-deficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies. JVirol2012; 86: 8516–8526.
18. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284: 816–819.
19. Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007; 449: 101–104.
20. Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, Bleeker WK et al. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 2009; 15: 951–954.
21. Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, Cheng-Mayer C. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. JVirol2003; 77: 989–998.
22. Humbert M, Rasmussen RA, Song R, Ong H, Sharma P, Chenine AL et al. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys. Retrovirology 2008; 5: 94.
23. Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci USA 1995; 92: 7490–7494.
24. Siddappa NB, Watkins JD, Wassermann KJ, Song R, Wang W, Kramer VG et al. R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models. PLoS One 2010; 5: e11689.
25. Rhesus Macaque Genome Sequencing and Analysis Consortium, Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007; 316: 222–234.
26. Sundling C, Li Y, Huynh N, Poulsen C, Wilson R, O’Dell S et al. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci Transl Med 2012; 4: 142ra96.
27. Zimin AV, Cornish AS, Maudhoo MD, Gibbs RM, Zhang X, Pandey S et al. A new rhesus macaque assembly and annotation for next-generation sequencing analyses. Biol Direct 2014; 9: 20.
28. Market E, Papavasiliou FN. V(D)J recombination and the evolution of the adaptive immune system. PLoS Biol 2003; 1: E16.
29. Sundling C, Martinez P, Soldemo M, Spångberg M, Bengtsson KL, Stertman L et al. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting. J Infect Dis 2013; 207: 426–431.
30. Sundling C, Phad G, Douagi I, Navis M, Karlsson Hedestam GB. Isolation of antibody V (D)J sequences from single cell sorted rhesus macaque B cells. J Immunol Methods 2012; 386: 85–93.
31. Sundling C, Zhang Z, Phad GE, Sheng Z, Wang Y, Mascola JR et al. Single-cell and deep sequencing of IgG-switched macaque B cells reveal a diverse Ig repertoire following immunization. JImmunol2014; 192: 3637–3644.
32. Lefranc M-P, Ehrenmann F, Ginestoux C, Giudicelli V, Duroux P. Use of IMGT(®) databases and tools for antibody engineering and humanization. Methods Mol Biol 2012; 907: 3–37.
33. Francica JR, Sheng Z, Zhang Z, Nishimura Y, Shingai M, Ramesh et al. Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization. Nat Commun 2015; 6: 6565.
34. Dai K, He L, Khan SN, O’Dell S, McKee K, Tran K et al. Rhesus macaque b-cell responses to an HIV-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis. MBio 2015; 6: e01375–01315.
35. Neumann B, Klippert A, Raue K, Sopper S, Stahl-Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol 2015; 97: 19–30.
36. Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009; 458: 636–640.
37. Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011; 477: 466–470.
38. McLellan JS, Pancera M, Carrico C, Gorman J, Julien J-P, Khayat R et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 2011; 480: 336–343.
39. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009; 326: 285–289.
40. Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA et al. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1–42 mannose residues on the outer face of gp120. J Virol 2002; 76: 7306–7321.
41. Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010; 329: 856–861.
42. Huang J, Ofek G, Laub L, Louder MK, Doria-Rose NA, Longo NS et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 2012; 491: 406–412.
43. Bonsignori M, Hwang K-K, Chen X, Tsao C-Y, Morris L, Gray E et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol 2011; 85: 9998–10009.
44. West AP, Diskin R, Nussenzweig MC, Bjorkman PJ. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 2012; 109: E2083–E2090.
45. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011; 333: 1633–1637.
46. Briney BS, Willis JR, Finn JA, McKinney BA, Crowe JE. Tissue-specific expressed antibody variable gene repertoires. PLoS One 2014; 9: e100839.
47. Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology 2012; 137: 56–64.
48. Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, DeKosky BJ et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 2014; 509: 55–62.
49. Georgiou G, Ippolito GC, Beausang J, Busse CE, Wardemann H, Quake SR. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol 2014; 32: 158–168.
50. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013; 79: 5112–5120.
51. Schirmer M, Ijaz UZ, D’Amore R, Hall N, Sloan WT, Quince C. Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform. Nucleic Acids Res 2015; 43: e37.
52. He L, Sok D, Azadnia P, Hsueh J, Landais E, Simek M et al. Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding. Sci Rep 2014; 4: 6778.
53. Yan G, Zhang G, Fang X, Zhang Y, Li C, Ling F et al. Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol 2011; 29: 1019–1023.
54. Eibel H, Kraus H, Sic H, Kienzler A-K, Rizzi M. B cell biology: an overview. Curr Allergy Asthma Rep 2014; 14: 434.
55. Yamamoto T, Lynch RM, Gautam R, Matus-Nicodemos R, Schmidt SD, Boswell KL et al. Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection. Sci Transl Med 2015; 7: 298ra120.
56. Navis M, Tran K, Bale S, Phad GE, Guenaga J, Wilson R et al. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization. PLoS Pathog 2014; 10: e1004337.
57. O’Connell AE, Volpi S, Dobbs K, Fiorini C, Tsitsikov E, de Boer H et al. Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome. Front Immunol 2014; 5: 340.
58. Galson JD, Clutterbuck EA, Trück J, Ramasamy MN, Münz M, Fowler et al. BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines. Immunol Cell Biol 2015; 93: 885–895.
59. Bagnara D, Squillario M, Kipling D, Mora T, Walczak AM, Da Silva L et al. A Reassessment of IgM Memory Subsets in Humans. J Immunol 2015; 195: 3716–3724.
60. Wang C, Liu Y, Cavanagh MM, Le Saux S, Qi Q, Roskin KM et al. B-cell repertoire responses to varicella-zoster vaccination in human identical twins. Proc Natl Acad Sci USA 2015; 112: 500–505.
61. Cortina-Ceballos B, Godoy-Lozano EE, Téllez-Sosa J, Ovilla-Muñoz M, Sámano-Sánchez H, Aguilar-Salgado et al. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain. Genome Med 2015; 7: 124.
62. Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013; 496: 469–476.
63. Georgiev IS, Doria-Rose NA, Zhou T, Kwon YD, Staupe RP, Moquin S et al. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 2013; 340: 751–756.
64. Walker LM, Sok D, Nishimura Y, Donau O, Sadjadpour R, Gautam R et al. Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proc Natl Acad Sci USA 2011; 108: 20125–20129.
65. Phad GE, Vázquez Bernat N, Feng Y, Ingale J, Martinez Murillo PA, O’Dell S et al. Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization. JImmunol2015; 194: 5903–5914.
66. Scheepers C, Shrestha RK, Lambson BE, Jackson KJL, Wright IA, Naicker D et al. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire. JImmunol2015; 194: 4371–4378.
67. Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011; 27: 2957–2963.
68. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011; 17: 10.
69. Ye J, Ma N, Madden TL, Ostell JM. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res 2013; 41: W34–W40.
70. Gupta NT, Vander Heiden JA, Uduman M, Gadala-Maria D, Yaari G, Kleinstein SH. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 2015; 31: 3356–3358.